Regeneron COVID-19 drug cocktail combats South Africa variant, Lilly's does not - study

Laboratory testing found that Regeneron Pharmaceuticals Inc’s COVID-19 antibody cocktail can combat a coronavirus variant first found in South Africa, but a similar drug from Eli Lilly and Co is inactive against it, according to a study released on Tuesday.